Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2022) 81 EP620 | DOI: 10.1530/endoabs.81.EP620

1Department of Endocrinology and Diabetology CHU Hedi Chaker Sfax, Tunisia; 2Faculty of Science, Sfax


Introduction: Multiple endocrine neoplasia type 2 is an inherited syndrome characterized by the characteristic combination of medullary thyroid cancer, pheochromocytoma and primary hyperparathyroidism. We report one case with phenotype-genotype mismatch.

Observation: Patient A. T is 45 years of age with a family history of thyroid bone marrow cancer (CMT) and sister brain cancer, father colon cancer, with no personal history of disease. A 60 mm long-axis left adrenaloma during a nephretic colic test with 4* normal urinary metanephrins. The diagnosis of primary hyperparathyroidism was raised in the presence of hypercalcemia: 2.9 mmol/l, Phosphoremia: 0.7 mmol/l and confirmed by normal PTH *. The topographic assessment concluded a parathyroid adenoma and a multinodular goiter. The absence of medullary thyroid cancer (CMT) decreased the probability of NEM2A but this is still possible. The patient received a left adrenalectomy. A The genetic study did not reveal any pathogenic variant or VSI.

Discussion-Conclusion: The association of pheochromocytoma, hyperparathyroidism and multinodular goiter, as well as the family history of CMT and cerebral cancer in the sister and colon cancer in the father, suggested a mutation that does not belong to the ROTERCC panel. Our observation attested to the value of conducting a genetic study for personalized medical care of patients and for establishing genetic counseling for patients and their families.

Volume 81

European Congress of Endocrinology 2022

Milan, Italy
21 May 2022 - 24 May 2022

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.

My recently viewed abstracts